AlivaMab Biologics
PrivateLast Round
Seed
May 1, 2018
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AlivaMab Biologics is a drug discovery company that provides fully integrated solutions for biologics drug discovery through its platform of innovative capability modules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlivaMab Biologics Comparables
Compare AlivaMab Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 86% | |
| Alloy Therapeutics | 80% | |
| Ablexis | 80% |
AlivaMab Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2018 |
Key People
Founding team and executive leadership
AlivaMab Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 115% MoM, reaching 2.9K.
- Aug 1, 2026
Open roles increased to 24, representing 73% of headcount.
AlivaMab Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AlivaMab Biologics's valuation, stock price, and market status.
Is AlivaMab Biologics a public or private company?
AlivaMab Biologics is a private company.
What is the current stock price of AlivaMab Biologics?
AlivaMab Biologics is a private company, so its shares have no public market price. Caplight tracks AlivaMab Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlivaMab Biologics worth (valuation)?
Valuation information for AlivaMab Biologics is not publicly available.
Can I buy AlivaMab Biologics stock?
AlivaMab Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlivaMab Biologics's last funding round?
AlivaMab Biologics's most recent funding round was Seed on May 1, 2018.
Who are the main investors in AlivaMab Biologics?
Key investors in AlivaMab Biologics include Deerfield Management.
Will AlivaMab Biologics IPO soon?
No public IPO plans have been announced for AlivaMab Biologics.
How can I track AlivaMab Biologics secondary market activity?
Caplight tracks bids, offers, and trades in AlivaMab Biologics's shares on secondary markets.